UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000028167 |
|---|---|
| Receipt number | R000032245 |
| Scientific Title | Factors Affecting the Hemodynamic Instability during Ventricular Rapid Pacing: Differential Predictors in Patients with Heart Failure with Preserved Ejection Fraction and Cardiac Resynchronized Therapy-Implanted Patients |
| Date of disclosure of the study information | 2017/07/11 |
| Last modified on | 2017/07/10 20:49:19 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Factors Affecting the Hemodynamic Instability during Ventricular Rapid Pacing: Differential Predictors in Patients with Heart Failure with Preserved Ejection Fraction and Cardiac Resynchronized Therapy-Implanted Patients
Acronym
Factors Affecting the Hemodynamic Instability during Ventricular Rapid Pacing: Differential Predictors in Patients with Heart Failure with Preserved Ejection Fraction and Cardiac Resynchronized Therapy-Implanted Patients
Scientific Title
Factors Affecting the Hemodynamic Instability during Ventricular Rapid Pacing: Differential Predictors in Patients with Heart Failure with Preserved Ejection Fraction and Cardiac Resynchronized Therapy-Implanted Patients
Scientific Title:Acronym
Factors Affecting the Hemodynamic Instability during Ventricular Rapid Pacing: Differential Predictors in Patients with Heart Failure with Preserved Ejection Fraction and Cardiac Resynchronized Therapy-Implanted Patients
Region
| Japan |
Condition
Condition
ventricular tachycardia
Classification by specialty
| Cardiology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To clear the hemodynamic response during ventricular rapid pacing and determine the factors that affect the blood pressure during VT in HF patients.
Basic objectives2
Others
Basic objectives -Others
risk stratification
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
The relationship between the cycle length of ventricular pacing and hemodynamics during ventricular tachycardia
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Prevention
Type of intervention
| Maneuver |
Interventions/Control_1
ventricular pacing
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 19 | years-old | <= |
Age-upper limit
| 88 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
The patients who underwent RFCA for paroxysmal/persistent atrial fibrillation and paroxysmal supraventricular tachycardia , premature ventricular contraction and idiopathic ventricular tachycardia or electrophysiologic study.
Key exclusion criteria
The patients with coronary artery disease, aortic valve disease and cardiovascular events within three months.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kazuki Noda |
Organization
Iwate Prefectural Central Hospital
Division name
Department of Cardiology
Zip code
Address
Ueda 1-4-1, Morioka city, Iwate prefecture, Japan
TEL
81-19-653-1151
a0mb1069-thk@umin.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kazuki Noda |
Organization
Iwate Prefectural Central Hospital
Division name
Department of Cardiology
Zip code
Address
Ueda 1-4-1, Morioka city, Iwate prefecture, Japan
TEL
81-19-653-1151
Homepage URL
a0mb1069-thk@umin.jp
Sponsor or person
Institute
Department of Cardiology, Iwate Prefectural Central Hospital
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2017 | Year | 07 | Month | 11 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2016 | Year | 03 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2016 | Year | 03 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2017 | Year | 07 | Month | 10 | Day |
Last modified on
| 2017 | Year | 07 | Month | 10 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032245
